palbociclib
pfizer
['dance', 'mbc', 'ts,perio,i', ' fulv', 'palbo', 'nsclc', 'sclc', 'ts,perio,1']
pada-1 (best study name ever after r2d2 for her2+ mnsclc right?). fulv + palbo was superior in the updated pfs results. pfs2 also with significant benefit besr1 mutations show promise on guidance of patients in mbc. #asco23 
Husband, Father. Medical Oncologist and Researcher focused in Thoracic Oncology.  Views are my own. Member of @latenightonc - the best podcast in oncology!